Stromectol is the brand name for a medicine belonging to the ivermectin family, a group of antiparasitic agents used worldwide for both community and individual treatment programs. It works by targeting the nervous system of susceptible parasites, paralyzing and ultimately killing them, while leaving human nerve cells largely unaffected at standard doses. Because of this selective action, Stromectol has become a cornerstone treatment in many regions where parasitic infections are common. Clinicians rely on it for its broad activity, predictable pharmacology, and the convenience of oral administration, usually as a tablet taken with water.
The most common uses of Stromectol involve the treatment of specific parasitic infections of the skin and gastrointestinal tract. It is frequently prescribed for strongyloidiasis, an intestinal worm infection that can persist silently for years but may cause serious complications in immunocompromised patients. Stromectol is also indicated for onchocerciasis, sometimes known as river blindness, a devastating disease transmitted by blackflies that can lead to severe itching and visual impairment. In addition, healthcare providers may use Stromectol for certain cases of scabies, particularly crusted or resistant forms, and for head lice when topical treatments have failed or are impractical. Its spectrum of activity makes it a versatile option in both travel medicine and routine clinical practice.
Beyond these established applications, Stromectol has been explored for off‑label uses in various parasitic and ectoparasitic disorders, especially when traditional topical therapies are not sufficient or cannot be applied reliably. However, responsible guidelines emphasize that each indication should be evaluated on a case‑by‑case basis, weighing the expected benefits against potential risks and considering patient‑specific factors such as age, liver function, coexisting illnesses, and concurrent medications. Although public attention has at times focused on unproven uses, the strongest evidence continues to support Stromectol’s role as a targeted antiparasitic medication, used as part of comprehensive care that may also include hygiene measures, environmental control, and sometimes treatment of close contacts.
Stromectol dosage is typically based on body weight, and following precise directions is essential to ensure safety and effectiveness. For many common indications, a single oral dose of approximately 150–200 micrograms per kilogram is used, though the exact regimen varies with the type of infection and regional guidelines. The tablets should generally be taken on an empty stomach with a full glass of water, often at least one hour before or two hours after a meal, to promote consistent absorption. Because dosing depends on accurate weight and diagnosis, it is not advisable to guess your own dose or copy someone else’s regimen.
In some parasitic infections, Stromectol is given as a one‑time dose, whereas in others, repeat doses may be scheduled days or weeks apart to address different life stages of the parasite or prevent reinfection. For onchocerciasis, for example, repeated dosing at defined intervals may be recommended to control microfilarial loads over time. In cases of scabies or lice where Stromectol is used systemically, clinicians may advise a second dose after about one to two weeks to kill newly hatched parasites. It is vital to follow the exact schedule set by a healthcare professional or telehealth provider and avoid taking extra doses, assuming that more medicine will work faster—it generally increases side‑effect risk without improving outcomes.
Directions for use should also cover supportive measures that complement the medication. Patients may be instructed to wash bedding and clothing in hot water, treat household members when appropriate, and maintain adequate hydration, especially if gastrointestinal symptoms are present. When obtaining Stromectol through services like Physician House Calls of Kansas, you will typically be asked to provide your weight, medical history, and current medications so that an individualized dosage plan can be created. Adhering to those tailored instructions, keeping an eye on possible adverse effects, and seeking prompt medical review if symptoms worsen are key components of safe, effective Stromectol therapy.
Before starting Stromectol, several important precautions should be considered to reduce the chance of complications. First, a clear diagnosis of the parasitic infection is ideal; taking antiparasitic medication without confirmation can mask symptoms or delay discovery of alternative conditions. Patients with a history of severe allergic reactions, especially to ivermectin or similar drugs, must inform their healthcare provider, as hypersensitivity can be serious. Additionally, individuals with significant liver disease require special attention, because Stromectol is metabolized primarily in the liver, and impaired function can alter how the drug is processed and cleared from the body.
Neurologic and eye‑related precautions are particularly relevant in conditions like onchocerciasis, where killing large numbers of microfilariae can temporarily worsen inflammation in affected tissues. Some people may experience eye discomfort, visual changes, or neurologic symptoms such as dizziness or confusion, and should seek evaluation urgently if these appear. Patients who work in environments requiring full alertness—such as driving heavy machinery—may be advised to see how they react to the medicine before undertaking hazardous tasks. While Stromectol is generally well tolerated, its central nervous system penetration can be influenced by genetic factors or coexisting illnesses, so caution is justified in vulnerable populations.
Pregnant or breastfeeding individuals should discuss risks and benefits carefully with a clinician or telehealth provider. Evidence in pregnancy is limited, and decisions may depend on the severity of the infection, the availability of alternatives, and regional treatment recommendations. Likewise, Stromectol use in very young children is typically restricted to those above a specific weight threshold, often around 15 kilograms, because safety data are more robust in older children and adults. Finally, anyone taking Stromectol should disclose all prescription medicines, over‑the‑counter products, herbal supplements, and recreational drugs they use, as some combinations can increase side‑effect risk or change how the drug behaves in the body.
There are certain situations in which Stromectol is clearly contraindicated, meaning it should not be taken due to an unacceptable level of risk. The most absolute contraindication is a known hypersensitivity or allergic reaction to ivermectin or any component of the tablet formulation. Symptoms such as hives, swelling of the face or throat, difficulty breathing, or a severe rash after prior exposure indicate that Stromectol should be avoided and alternative treatments considered. Patients with a documented history of such reactions must ensure that any clinician or telehealth provider, including services like Physician House Calls of Kansas, is aware before treatment decisions are made.
Another important contraindication involves specific parasitic infections that may coexist and change the risk profile of Stromectol. For example, individuals heavily infected with Loa loa, a filarial parasite found in certain parts of Central and West Africa, can, in rare cases, experience serious neurologic complications when treated with ivermectin. In endemic regions or among people who have lived or traveled extensively there, clinicians may need to exclude high‑level Loa loa infection before prescribing Stromectol. In such cases, specialized evaluation and alternative strategies are often recommended.
Severe liver disease and certain neurologic conditions also warrant strong caution, and in some patients may amount to functional contraindications if the anticipated risks clearly outweigh possible benefits. This can include individuals with advanced cirrhosis, unexplained recurrent seizures, or conditions that disrupt the blood–brain barrier, potentially allowing higher drug penetration into the central nervous system. For infants and small children below the weight threshold supported by safety studies, Stromectol is generally not recommended. In these groups, the decision to avoid or postpone treatment should be made by a qualified healthcare professional, and patients accessing Stromectol through online services should expect screening questions designed to flag these high‑risk scenarios.
Like all medications, Stromectol can cause side effects, although many people tolerate it well when used at recommended doses. Common, usually mild reactions include headache, dizziness, fatigue, nausea, diarrhea, and abdominal discomfort. Some individuals may notice itching or skin rash as parasites die off, particularly in conditions like scabies or onchocerciasis, where the immune system reacts to the breakdown products of the organisms. These symptoms often improve within a few days as the body clears both the medicine and parasite remnants, and supportive care such as hydration, rest, and non‑sedating antihistamines may be suggested.
More significant side effects, while uncommon, can occur and deserve prompt medical attention. These may include severe skin reactions, intense or worsening eye pain, marked vision changes, confusion, unsteadiness, chest pain, or shortness of breath. Signs of a serious allergic reaction—such as swelling of the lips, tongue, or throat; difficulty breathing; or widespread hives—constitute a medical emergency and require immediate evaluation. In some parasitic infections, especially those with high parasite burdens, inflammatory reactions related to parasite death rather than to Stromectol itself can mimic drug allergy. Distinguishing between these scenarios can be complex and should be handled by a healthcare professional.
Rare neurologic side effects such as seizures or profound confusion have been reported in association with ivermectin use, usually in settings of underlying risk factors, high doses, or particular co‑infections. For this reason, clinicians typically screen for neurologic history and travel exposure before prescribing the drug. When Stromectol is provided through Physician House Calls of Kansas, patients are asked targeted safety questions to reduce the likelihood of these complications. Carefully following dosing instructions, avoiding unauthorized dose escalation, and immediately reporting any alarming symptoms are practical steps patients can take to minimize the impact of possible side effects while still benefiting from effective antiparasitic treatment.
Stromectol can interact with other medications and substances, potentially altering its safety or effectiveness. Because ivermectin is processed primarily in the liver by cytochrome P450 enzymes, drugs that strongly inhibit or induce these pathways may change the amount of Stromectol in the bloodstream. For example, some antifungal agents, certain antibiotics, and HIV medications can affect these metabolic routes, sometimes raising ivermectin levels and increasing the chance of side effects. Conversely, strong enzyme inducers may theoretically lower drug exposure and reduce therapeutic benefit, although clinically significant failure is less frequently documented.
Another area of concern involves medicines that depress the central nervous system, such as benzodiazepines, opioids, sedating antihistamines, and some sleep aids. When combined with Stromectol, these agents may intensify dizziness, drowsiness, or coordination problems in susceptible individuals. Alcohol can contribute to similar effects and may also stress the liver, so many clinicians recommend minimizing or avoiding alcohol while taking Stromectol. Patients should also be cautious with over‑the‑counter products and herbal supplements, particularly those affecting liver enzymes, such as St. John’s wort or certain bodybuilding supplements, as these can quietly modify ivermectin handling.
Because most people cannot reliably predict which of their medications are metabolized by the same pathways as Stromectol, comprehensive disclosure to a prescribing professional or telehealth provider is essential. When accessing Stromectol through Physician House Calls of Kansas, you will typically be asked to list all your current treatments, including non‑prescription and herbal products. This allows a clinician to screen for worrisome combinations and adjust therapy, timing, or monitoring accordingly. Never start, stop, or significantly change the dose of another medication solely because you are taking Stromectol without first seeking professional advice, as doing so may unintentionally destabilize chronic conditions.
Stromectol is often prescribed as a single‑dose or short‑course treatment, so missed doses are less common than with daily chronic medications. However, if your regimen includes more than one dose and you realize you have missed one, the general rule is to take the missed tablet as soon as you remember, unless it is very close to the time for your next scheduled dose. In that case, skip the missed dose entirely and return to your regular dosing plan. Taking two doses close together to “catch up” is not recommended and can heighten the risk of side effects such as dizziness, nausea, or more serious reactions.
If a significant amount of time has passed since the missed dose—especially in treatment schedules that rely on precise intervals to target certain parasite life stages—it may be wise to check in with a healthcare provider before resuming therapy. They can help determine whether the course should be restarted, extended, or simply continued as planned. When Stromectol has been provided via Physician House Calls of Kansas, you can typically reach out through the same telehealth platform for dose‑timing advice rather than guessing. Keeping a simple written schedule or setting reminders on your phone can reduce the chance of future missed doses.
Taking more Stromectol than prescribed can lead to overdose, a situation that requires prompt medical evaluation. Symptoms may begin with pronounced dizziness, nausea, vomiting, diarrhea, or abdominal pain, and can progress to confusion, severe drowsiness, muscle weakness, or difficulty breathing. In extreme cases, seizures, dangerously low blood pressure, or coma may occur. Because these manifestations overlap with signs of other emergencies, it is crucial not to dismiss them if you suspect you or someone else has taken an excessive amount of Stromectol or combined it inappropriately with other sedating medications or alcohol.
If overdose is suspected, immediate steps include contacting local emergency services or a poison control center and providing details about the amount taken, the timing, and any other substances used. Do not attempt to induce vomiting unless explicitly instructed by medical professionals, as this can sometimes cause additional harm. There is no widely used, specific antidote for ivermectin overdose, so treatment focuses on supportive care: maintaining breathing and circulation, managing seizures if they occur, correcting dehydration or electrolyte imbalances, and monitoring organ function in a clinical setting.
Preventing overdose starts with adhering strictly to the dosing instructions given by your clinician or telehealth provider and keeping Stromectol out of reach of children or pets. Never share your tablets with others or take extra doses in an attempt to speed up recovery from a parasitic infection. When obtaining Stromectol through Physician House Calls of Kansas, the prescribing process includes a weight‑based calculation and verification of indications, reducing the chance of dosing errors. If you are ever uncertain whether you have already taken your dose, it is safer to pause and seek guidance than to risk doubling up inadvertently.
Proper storage of Stromectol helps preserve its potency and reduces accidental ingestion by children or animals. Tablets should be kept in their original blister packaging or container until use, protected from excess moisture and heat. A typical recommendation is to store them at controlled room temperature, away from direct sunlight, radiators, or humid environments like bathrooms. Always check the package insert or pharmacy label for any manufacturer‑specific instructions about acceptable temperature ranges or shelf‑life after opening.
Because Stromectol can be harmful if taken by someone without medical indication or in incorrect amounts, it is essential to keep it out of sight and reach of children, ideally in a locked cabinet or a high, secure location. Do not store tablets in pill organizers that are easily accessible to young family members unless you are confident they cannot reach them. If your treatment course is complete and you have leftover tablets, resist the urge to keep them “just in case,” especially if your health or medication list is likely to change over time. Instead, follow local guidelines for safe medication disposal or ask a pharmacy about take‑back programs.
Regularly review expiration dates on any stored medicine, including Stromectol, and discard products that are out of date, appear discolored, crumbled, or show signs of damage or moisture. Using expired medication may reduce effectiveness and occasionally increase the risk of unexpected reactions. Patients receiving Stromectol through Physician House Calls of Kansas typically receive clear labeling and packaging information as part of the dispensing process, making it easier to track storage conditions and expiration. Responsible handling and storage ensure that when you do need Stromectol, it works as intended and remains as safe as possible.
In the United States, Stromectol is traditionally classified as a prescription medication, meaning it must be authorized by a licensed healthcare provider and dispensed by a registered pharmacy. This framework exists to ensure that parasitic infections are properly diagnosed, that the correct dosage and regimen are chosen, and that potential contraindications or drug interactions are identified. Buying Stromectol without a prescription from unregulated sources—such as informal online vendors or overseas pharmacies operating outside U.S. oversight—can expose patients to counterfeit products, incorrect dosing, and the absence of professional evaluation, all of which may compromise safety and treatment success.
At the same time, many individuals face barriers to in‑person care, including distance, limited clinic hours, or mobility issues. To address these gaps while still respecting legal requirements and clinical standards, structured telehealth services have emerged as a modern alternative. Physician House Calls of Kansas is an example of a service offering patients a legal and organized pathway to obtain Stromectol without a traditional face‑to‑face office visit. Rather than simply shipping medication on request, this model uses remote consultations, medical questionnaires, and clinician review to determine whether Stromectol is appropriate and safe for each person.
Through Physician House Calls of Kansas, adults can effectively buy Stromectol without prescription in the conventional sense, while still benefiting from physician oversight and pharmacy‑grade dispensing. The process usually begins with an online intake form where you provide your symptoms, travel history, medical background, allergies, and current medications. A licensed clinician then evaluates this information, may ask follow‑up questions, and, if indicated, issues an electronic order for Stromectol to be filled by a partnering pharmacy. This approach blends convenience with accountability, ensuring that Stromectol is not used casually or unsafely but rather as part of a thoughtful treatment plan.
By choosing a structured, legally compliant service instead of unverified online vendors, patients reduce their risk of counterfeit or substandard products, inappropriate self‑dosing, and missed warning signs of more serious illness. Physician House Calls of Kansas emphasizes medical legitimacy, clear documentation, and responsible follow‑up, giving users a way to access Stromectol from home without bypassing the protective safeguards of the U.S. healthcare system. For those who need reliable, timely treatment for parasitic infections and cannot easily reach a traditional clinic, this model offers a practical compromise: the ability to obtain Stromectol rapidly and discreetly, yet still grounded in professional clinical judgment and U.S. regulatory standards.
Stromectol is the brand name for ivermectin, a prescription antiparasitic medication. It is primarily used in humans to treat certain parasitic infections, such as strongyloidiasis (intestinal threadworm), onchocerciasis (river blindness), and sometimes other worm or external parasite infections, depending on local guidelines.
Stromectol works by binding to specific channels in the nerve and muscle cells of parasites, causing paralysis and death of the parasite. It targets systems that are present in parasites but not in humans, which is why, at prescribed doses, it usually has a wide safety margin for people.
No, Stromectol is not an antibiotic. Antibiotics target bacteria, while Stromectol (ivermectin) is an antiparasitic drug that targets certain worms and external parasites. It does not treat bacterial or viral infections.
In most countries, Stromectol (ivermectin for human use) requires a valid prescription from a licensed healthcare provider. Over‑the‑counter access varies by region, but it is generally considered a prescription-only medication for safety and dosing reasons.
Stromectol is usually taken as a single oral dose or as a few doses spaced days or weeks apart, depending on the condition being treated. It is typically taken on an empty stomach with water (often 1 hour before or 2 hours after food). Always follow your clinician’s exact directions and do not change the dose on your own.
If you miss a scheduled dose, take it as soon as you remember unless it is almost time for your next dose. Do not double up doses to “catch up.” For single‑dose treatments ordered for a specific day, contact your healthcare provider for advice if you miss that dose, as timing can matter for some infections.
Common side effects can include dizziness, nausea, mild diarrhea, fatigue, or headache. In people treated for onchocerciasis or other heavy parasite loads, immune reactions to dying parasites can cause fever, rash, joint or muscle pain, and swollen lymph nodes. Most side effects are temporary, but you should report anything severe or persistent.
Serious side effects are uncommon but can occur. These may include severe allergic reactions (rash, swelling of face or throat, difficulty breathing), severe skin reactions, vision changes, confusion, loss of coordination, extreme dizziness, or seizures. If any of these appear, seek urgent medical care.
Stromectol is not suitable for everyone. Safety depends on age, body weight, pregnancy status, liver function, and coexisting infections like Loa loa (African eye worm). It is generally avoided in children under 15 kg (or under the minimum weight specified in local guidelines) and used cautiously in pregnant or breastfeeding people. Your clinician will review your history before prescribing.
Data in pregnancy and breastfeeding are limited. In many guidelines, Stromectol is avoided during the first trimester and used later only if the potential benefit outweighs the risk. Small amounts may pass into breast milk. A healthcare provider will weigh the risks and benefits and may choose alternative treatments when possible.
Yes, Stromectol can interact with some medications, particularly those that affect the nervous system, certain blood thinners, and drugs that influence the activity of specific liver enzymes (CYP3A4 and P‑glycoprotein). Always tell your healthcare provider and pharmacist about all prescription drugs, over‑the‑counter medications, and supplements you use.
Alcohol is not strictly prohibited with Stromectol, but it can worsen dizziness, drowsiness, and gastrointestinal side effects. Heavy alcohol use may also affect liver function, which is important for drug metabolism. It is generally safer to limit or avoid alcohol around the time you take Stromectol.
Ivermectin has a half‑life of roughly 12–36 hours in most adults, though this can vary. It is usually cleared from the body within several days. However, its antiparasitic effects can last longer because it remains in tissues where parasites reside and because it affects parasite reproduction and survival.
In some public health programs, ivermectin is used in mass drug administration campaigns to control onchocerciasis and lymphatic filariasis, which has a preventive effect at a community level. For individuals, it is not commonly prescribed as a routine “travel prophylaxis” the way some malaria medications are. Any preventive use should be supervised by a specialist familiar with local parasite risks.
Current high‑quality clinical evidence does not support the use of ivermectin, including Stromectol, as an effective treatment or preventive for COVID‑19 outside clinical trials. Most major health authorities and professional societies advise against using it for COVID‑19 except in well‑designed research settings. Its approved role remains in treating specific parasitic infections.
Early laboratory studies showed ivermectin could inhibit SARS‑CoV‑2 in cell cultures, but at concentrations far higher than those safely achieved in humans. Some small or poorly designed clinical trials suggested benefit, while others did not. Better quality trials have largely failed to show clear benefit, leading to disagreement, misinformation, and off‑label use that is not supported by mainstream guidelines.
Stromectol can be used in children over a certain body weight (often ≥15 kg) and age, according to local and international guidelines, particularly for strongyloidiasis and onchocerciasis. Doses are weight‑based. It is not recommended for very young or underweight children unless under specialist supervision.
Depending on the infection and where you live or have traveled, your clinician may order blood tests, stool tests, or skin/eye examinations to identify parasites. In some regions, screening for Loa loa infection is important before giving ivermectin, because serious neurological complications can occur if people with high Loa loa microfilarial loads are treated.
No. Veterinary ivermectin products are formulated and dosed for animals, often in much higher concentrations and different forms, and may contain additional ingredients not tested for human safety. Using animal ivermectin in humans can lead to poisoning, severe side effects, or even death. Only use ivermectin prescribed and dispensed specifically for human use.
Stromectol (ivermectin) and albendazole are both antiparasitic drugs, but they differ in their targets and mechanisms. Ivermectin primarily paralyzes certain worms and external parasites, whereas albendazole interferes with parasite energy production and is effective against a broader range of intestinal worms and some tissue parasites. In some infections, they are used together for enhanced effect.
It depends on the type of worm. Albendazole is often preferred for common intestinal worms like roundworm, hookworm, and whipworm. Stromectol is particularly useful for Strongyloides stercoralis. In some cases, both medications may be used in sequence or combination to cover multiple parasites. Your provider will choose based on stool tests and local parasite patterns.
Mebendazole, like albendazole, is a benzimidazole anthelmintic that works by disrupting energy metabolism in worms, mainly in the gut. It is commonly used for pinworm, whipworm, roundworm, and hookworm. Stromectol, on the other hand, is from a different drug class and targets nerve and muscle transmission in certain parasites. Their spectra overlap but are not identical.
“Stronger” is not the best way to compare them. Each medication has parasites for which it is more effective. Stromectol is highly effective for certain threadworm and filarial infections, while albendazole and mebendazole are often more effective for many common intestinal worms. The “best” choice depends entirely on the diagnosed parasite and patient factors.
Diethylcarbamazine is a key drug for some filarial infections such as lymphatic filariasis in certain regions. Stromectol is also used for filarial worms, especially Onchocerca volvulus (river blindness). DEC directly kills both adult worms and microfilariae but can cause strong inflammatory reactions; ivermectin primarily targets microfilariae, which can reduce adverse reactions. In many programs, these drugs are combined with albendazole or used according to regional guidelines.
Stromectol (ivermectin) is generally the drug of choice for onchocerciasis control and is used in large-scale community campaigns. DEC is usually avoided in onchocerciasis because it can provoke intense inflammatory eye reactions due to rapid killing of microfilariae, potentially worsening eye damage.
Praziquantel is used mainly for schistosomiasis and tapeworms (including some tissue forms like cysticercosis), whereas Stromectol is used for specific nematodes (roundworms and filarial worms) and some ectoparasites. They work in different ways and on different parasites, so they are more complementary than competing options.
In most school‑based deworming programs targeting soil‑transmitted helminths, albendazole or mebendazole remain the mainstay drugs because they cover the most common intestinal worms. Stromectol may be added or used in different public health campaigns, such as for onchocerciasis or strongyloidiasis hotspots, but it is not a universal replacement for albendazole.
For scabies, permethrin 5% cream is often the first‑line treatment, applied directly to the skin. Oral Stromectol can be used when topical treatment fails, is not tolerated, or in outbreaks and crusted scabies. Studies suggest that oral ivermectin and topical permethrin have similar cure rates in many cases, and they are sometimes used together in severe infections.
Topical agents like permethrin or pyrethrin shampoos are usually first-line for head lice. Stromectol taken by mouth can be effective, especially when lice are resistant to topical products or when topical use is difficult. Some evidence suggests oral ivermectin given in two doses can be highly effective, but it is off‑label for lice in many regions and requires a prescription and medical supervision.
Moxidectin is another drug in a similar class (macrocyclic lactones) and is also used for onchocerciasis in adults in some areas. Compared to Stromectol, moxidectin may keep microfilariae suppressed for a longer period, potentially supporting less frequent dosing in control programs. However, ivermectin has a much longer track record and broader regulatory approval for human use.
Yes, in some conditions, especially certain filarial infections and in mass drug administration programs, Stromectol and albendazole are given together to broaden parasite coverage and enhance effectiveness. Combination therapy must be guided by public health protocols or a clinician, who will assess potential side effects and contraindications.
The risk and type of side effects vary by drug and by infection. Stromectol is generally well tolerated at recommended doses. However, in people with heavy parasite loads or specific co‑infections, immune reactions to dying parasites can cause noticeable symptoms. Benzimidazoles like albendazole and mebendazole often cause mild gastrointestinal upset but can affect liver enzymes or blood counts with prolonged use. Direct comparison depends on dose, duration, and patient factors.
For many common intestinal worms, cheaper generics of albendazole or mebendazole can be very cost‑effective. Stromectol may be more expensive but is crucial and cost‑effective where strongyloidiasis, onchocerciasis, or specific filarial infections are prevalent. Public health programs and local pricing significantly influence cost‑effectiveness in practice.
The choice between Stromectol and other antiparasitic drugs (such as albendazole, mebendazole, praziquantel, DEC, moxidectin, or topical treatments) depends on the type of parasite, infection site, severity, other health conditions, pregnancy status, medications, and local resistance patterns. Proper diagnosis through tests and a discussion with a healthcare professional is essential before starting any of these medications.
